J. Goldman & Co’s Merck MRK Stock Holding History

J. Goldman & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92M	Buy	+16,000	New	+$1.85M	0.06%	323
2025 Q2	–	Sell	-70,000	Closed	-$6.28M	–	572
2025 Q1	$6.28M	Sell	70,000 -50,000	-42%	-$4.67M	0.16%	183
2024 Q4	$11.9M	Buy	+120,000	New	+$12.4M	0.31%	100
2024 Q3	–	Sell	-100,000	Closed	-$12.4M	–	559
2024 Q2	$12.4M	Buy	100,000 +40,300	+68%	+$5.19M	0.35%	93
2024 Q1	$7.88M	Sell	59,700 -55,800	-48%	-$6.88M	0.25%	118
2023 Q4	$12.6M	Buy	115,500 +50,500	+78%	+$5.24M	0.51%	65
2023 Q3	$6.69M	Buy	+65,000	New	+$7.01M	0.23%	118
2023 Q2	–	Sell	-135,000	Closed	-$14.4M	–	452
2023 Q1	$14.4M	Buy	+135,000	New	+$14.6M	0.58%	50
2022 Q4	–	Sell	-75,000	Closed	-$6.46M	–	449
2022 Q3	$6.46M	Buy	+75,000	New	+$6.7M	0.31%	97
2021 Q4	–	Sell	-127,700	Closed	-$9.59M	–	402
2021 Q3	$9.59M	Buy	+127,700	New	+$9.71M	0.48%	53
2020 Q4	–	Sell	-108,258	Closed	-$8.57M	–	450
2020 Q3	$8.57M	Buy	+108,258	New	+$8.48M	0.58%	51
2013 Q3	–	Sell	-118,424	Closed	-$5.25M	–	295
2013 Q2	$5.25M	Buy	+118,424	New	+$5.29M	0.54%	59

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

J. Goldman & Co's MRK Position: Q2 2025 in Review

J. Goldman & Co sold out of Merck (MRK) in Q2 2025, closing a stake of 17,518 shares — an estimated $1.57M sold.

J. Goldman & Co first reported a position in MRK in Q2 2013 and held it in 14 quarters. The position peaked at $79.9M in Q2 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

J. Goldman & Co reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
J. Goldman & Co sold 17,518 Merck shares in Q2 2025, an estimated $1.57M.
J. Goldman & Co first reported a position in Merck in Q2 2013 and held it in 14 quarters.
J. Goldman & Co's Merck position peaked at $79.9M in Q2 2024.
3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on J. Goldman & Co's 13F filing for Q2 2025, filed 14 Aug 2025.